Hepatic Morphological Alterations Induced by Zidovudine (ZDV) in an Experimental Model
- 31 December 1996
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 192 (2) , 182-187
- https://doi.org/10.1016/s0344-0338(96)80218-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Hepatomegaly with severe steatosis in HIV-seropositive patientsAIDS, 1993
- Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria.Journal of Clinical Investigation, 1992
- Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infectionPathology, 1992
- Alternative therapies in HIV infectionAIDS, 1990
- Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Severe Polymyositis-like Syndrome Associated with Zidovudine Therapy of AIDS and ARCNew England Journal of Medicine, 1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985
- Induction of Endogenous Virus and of Thymidine Kinase by Bromodeoxyuridine in Cell Cultures Transformed by Friend VirusProceedings of the National Academy of Sciences, 1974
- Nucleosides. V. The Monomesylates of 1-(2'-Deoxy-β-D-lyxofuranosyl)thymine1,2The Journal of Organic Chemistry, 1964